Neuland Lab Standalone December 2023 Net Sales at Rs 392.83 crore, up 45.9% Y-o-Y

February 09, 2024 / 01:07 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Standalone quarterly numbers for Neuland Laboratories are:Net Sales at Rs 392.83 crore in December 2023 up 45.9% from Rs. 269.25 crore in December 2022.
Quarterly Net Profit at Rs. 80.70 crore in December 2023 up 165.15% from Rs. 30.44 crore in December 2022.
EBITDA stands at Rs. 122.66 crore in December 2023 up 123.51% from Rs. 54.88 crore in December 2022.
Neuland Lab EPS has increased to Rs. 62.90 in December 2023 from Rs. 23.72 in December 2022.Neuland Lab shares closed at 6,527.65 on February 08, 2024 (NSE) and has given 69.09% returns over the last 6 months and 351.68% over the last 12 months.
Neuland Laboratories
Standalone Quarterly Resultsin Rs. Cr.
Dec'23Sep'23Dec'22
Net Sales/Income from operations392.83417.75269.25
Other Operating Income------
Total Income From Operations392.83417.75269.25
EXPENDITURE
Consumption of Raw Materials153.45139.13132.00
Purchase of Traded Goods------
Increase/Decrease in Stocks-11.2212.78-26.45
Power & Fuel------
Employees Cost63.3466.4949.89
Depreciation15.1414.5113.34
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses66.6962.0659.86
P/L Before Other Inc. , Int., Excpt. Items & Tax105.42122.7940.61
Other Income2.103.050.93
P/L Before Int., Excpt. Items & Tax107.52125.8441.54
Interest3.744.432.74
P/L Before Exceptional Items & Tax103.78121.4038.80
Exceptional Items------
P/L Before Tax103.78121.4038.80
Tax23.0832.348.36
P/L After Tax from Ordinary Activities80.7089.0630.44
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period80.7089.0630.44
Equity Share Capital12.9012.9012.90
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS62.9069.4223.72
Diluted EPS62.9069.4223.72
EPS After Extra Ordinary
Basic EPS62.9069.4223.72
Diluted EPS62.9069.4223.72
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

Tags: #Earnings First-Cut #Neuland Lab #Neuland Laboratories #Pharmaceuticals #Results
first published: Feb 9, 2024 12:44 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!